![]() BioLoomics BioLoomics is a preclinical-stage biotechnology company leveraging the directed evolution of antibodies in human cells to create target-degrading antibodies. | ||
Founding Date | Founding Date 2018 | Founding Date 2019 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Boston, US HQ | Locations Boulder, US HQ |
Employees | Employees 814% increase | Employees 1616% decrease |
Funding | ||
Latest funding round | Latest funding round $ 5.5m (over 6 years ago) | Latest funding round $ 8.7m (almost 3 years ago) |
Total funding raised | Total funding raised $ 5.5m | Total funding raised $ 19.5m |

BioLoomics is a preclinical-stage biotechnology company leveraging the directed evolution of antibodies in human cells to create target-degrading antibodies.
View company